Cell Discovery (Aug 2024)

40 Hz light flickering facilitates the glymphatic flow via adenosine signaling in mice

  • Xiaoting Sun,
  • Liliana Dias,
  • Chenlei Peng,
  • Ziyi Zhang,
  • Haoting Ge,
  • Zejun Wang,
  • Jiayi Jin,
  • Manli Jia,
  • Tao Xu,
  • Wei Guo,
  • Wu Zheng,
  • Yan He,
  • Youru Wu,
  • Xiaohong Cai,
  • Paula Agostinho,
  • Jia Qu,
  • Rodrigo A. Cunha,
  • Xuzhao Zhou,
  • Ruiliang Bai,
  • Jiang-fan Chen

DOI
https://doi.org/10.1038/s41421-024-00701-z
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 17

Abstract

Read online

Abstract The glymphatic-lymphatic system is increasingly recognized as fundamental for the homeostasis of the brain milieu since it defines cerebral spinal fluid flow in the brain parenchyma and eliminates metabolic waste. Animal and human studies have uncovered several important physiological factors regulating the glymphatic system including sleep, aquaporin-4, and hemodynamic factors. Yet, our understanding of the modulation of the glymphatic system is limited, which has hindered the development of glymphatic-based treatment for aging and neurodegenerative disorders. Here, we present the evidence from fluorescence tracing, two-photon recording, and dynamic contrast-enhanced magnetic resonance imaging analyses that 40 Hz light flickering enhanced glymphatic influx and efflux independently of anesthesia and sleep, an effect attributed to increased astrocytic aquaporin-4 polarization and enhanced vasomotion. Adenosine-A2A receptor (A2AR) signaling emerged as the neurochemical underpinning of 40 Hz flickering-induced enhancement of glymphatic flow, based on increased cerebrofluid adenosine levels, the abolishment of enhanced glymphatic flow by pharmacological or genetic inactivation of equilibrative nucleotide transporters-2 or of A2AR, and by the physical and functional A2AR–aquaporin-4 interaction in astrocytes. These findings establish 40 Hz light flickering as a novel non-invasive strategy of enhanced glymphatic flow, with translational potential to relieve brain disorders.